Trial PaperAnxiety DisordersDepressive DisordersMajor Depressive Disorder (MDD)PeripartumKetamine

The effect of ketamine on preventing postpartum depression

In a double‑blind randomised trial of 134 women undergoing scheduled caesarean section, a single 0.5 mg/kg dose of ketamine given during anaesthetic induction significantly lowered Edinburgh Postnatal Depression Scale scores at two and four weeks versus control. These findings indicate ketamine may help prevent postpartum depression, but larger studies are required to confirm efficacy and safety.

Authors

  • Alipoor, M.
  • Loripoor, M.
  • Kazemi, M.

Published

Journal of Medicine and Life
individual Study

Abstract

Postpartum depression is a common disabling psychosocial disorder that could have adverse effects on the life of the mother, infant, and family. The present study was conducted to evaluate the effect of ketamine on preventing postpartum depression in women undergoing caesarian sections considering the relatively known positive effect of ketamine on major depression. The present double-blind, randomized clinical trial was conducted on 134 women undergoing scheduled caesarian sections. Participants were randomly allocated into two groups of control and intervention. To induce anesthesia, 1–2 mg/kg of body weight of Nesdonal and 0.5 mg/kg of body weight of ketamine were used in the intervention group, while only 3–5 mg/kg of body weight Nesdonal was administered in the control group. Data were gathered using the Edinburgh Postnatal Depression Scale (EPDS) in three stages: before the caesarian section and two and four weeks after the caesarian section. Data were analyzed using variance analysis with repeated measures and the Chi-square test. Results of the present study showed that the mean (± standard deviation) of the depression score in the intervention and control groups were 13.78±3.87 and 13.79±4.78(p = 0.98) before the caesarian section, 11.82±3.41 and 14.34±4.29 (p < 0.001) two weeks after and 10.84±3.48 and 13.09±3.79 (p = 0.001) four weeks after the caesarian section, respectively. Using ketamine in the induction of general anesthesia could be effective in preventing postpartum depression. However, further studies are required to strengthen these findings.

Available with Blossom Pro

Research Summary of 'The effect of ketamine on preventing postpartum depression'

Introduction

Postpartum depression is described as a common and disabling condition with reported prevalence estimates of 10% to 15% globally and higher reported rates in Iran (25% to 42.1%). The paper emphasises the broad negative consequences of postpartum depression for mothers, infants and families, including impairments in mother–infant interaction, reduced neonatal care, and economic costs, and notes that many affected women do not seek or continue standard pharmacological treatment during breastfeeding. Alipoor and colleagues set out to evaluate whether administering a single low dose of intravenous ketamine during induction of general anaesthesia for elective caesarean section could prevent postpartum depression. The study addresses a gap in the literature: while ketamine’s rapid antidepressant effects are well described in treatment-resistant major depression, its prophylactic potential for postpartum depression during caesarean section has been little studied.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

Related Clinical Trial

References (4)

Papers cited by this study that are also in Blossom

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature

Grady, S. E., Marsh, T. A., Tenhouse, A. et al. · Mental Health Clinician (2017)

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

Wilkinson, S. T., Ballard, E. D., Bloch, M. H. et al. · American Journal of Psychiatry (2017)

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

Grunebaum, M. F., Galfalvy, H. C., Choo, T. H. et al. · American Journal of Psychiatry (2018)

371 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.